Atlas Trials

Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients

Clinical trial NCT02071719 · TERMINATED

Trial details

NCT number
NCT02071719
Sponsor
M. Labots
Status
TERMINATED
Study type
OBSERVATIONAL
Renal Cell Cancer
Start date
2012-04-01
Primary completion
2017-10-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.